Patents by Inventor Robert Todd Striker

Robert Todd Striker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of bacterial pasta kinases
    Patent number: 11820753
    Abstract: Biochemically active PASTA kinase inhibitors which exploit subtle structural differences between human kinases and bacterial PASTA kinases to improve specificity and inhibitor activity.
    Type: Grant
    Filed: February 10, 2021
    Date of Patent: November 21, 2023
    Assignees: Wisconsin Alumni Research Foundation, U.S. Dept. of Veterans Affairs
    Inventors: Robert Todd Striker, Nathan Joseph Wlodarchak, John Bruce Feltenberger, Jennifer Golden
  • INHIBITORS OF BACTERIAL PASTA KINASES
    Publication number: 20230060122
    Abstract: Biochemically active PASTA kinase inhibitors which exploit subtle structural differences between human kinases and bacterial PASTA kinases to improve specificity and inhibitor activity.
    Type: Application
    Filed: February 10, 2021
    Publication date: February 23, 2023
    Inventors: Robert Todd Striker, Nathan Joseph Wlodarchak, John Bruce Feltenberger, Jennifer Golden
  • INHIBITORS OF BACTERIAL PASTA KINASES
    Publication number: 20220251062
    Abstract: Biochemically active PASTA kinase inhibitors which exploit subtle structural differences between human kinases and bacterial PASTA kinases to improve specificity and inhibitor activity.
    Type: Application
    Filed: February 10, 2021
    Publication date: August 11, 2022
    Inventors: Robert Todd Striker, Nathan Joseph Wlodarchak, John Bruce Feltenberger, Jennifer Golden
  • Use of kinase inhibitors to increase the susceptibility of gram positive bacteria to beta lactam antibiotics
    Patent number: 9540369
    Abstract: Methods of using certain kinase inhibitors for treating Gram positive bacterial infections are disclosed. When co-administered with a ?-lactam antibiotic, the disclosed compounds increase the susceptibility of infectious Gram positive bacteria to the ?-lactam antibiotic.
    Type: Grant
    Filed: April 24, 2015
    Date of Patent: January 10, 2017
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Robert Todd Striker, John-Demian Sauer, Nathan Wlodarchak
  • Use of Kinase Inhibitors to Increase the Susceptibility of Gram Positive Bacteria to Beta Lactam Antibiotics
    Publication number: 20150307495
    Abstract: Methods of using certain kinase inhibitors for treating Gram positive bacterial infections are disclosed. When co-administered with a ?-lactam antibiotic, the disclosed compounds increase the susceptibility of infectious Gram positive bacteria to the ?-lactam antibiotic.
    Type: Application
    Filed: April 24, 2015
    Publication date: October 29, 2015
    Inventors: Robert Todd Striker, John-Demian Sauer, Nathan Wlodarchak